Amgen negotiates 2 large anemia drug contracts with DaVita and Fresenius. PDF Print
LA Times: Amgen Inc., aiming to secure future sales of its flagship anemia drug Epogen as potential competition emerges, has reached new supply contracts with the two largest operators of U.S. kidney dialysis clinics.

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.